Recent reports have identified TET2, a gene encoding the enzyme which catalyzes 5-methylcytosine to 5-hydroxymethylcytosine, to be frequently mutated in AML, and TET mutations are mutually exclusive with IDH1/2 mutations in AML [28-30]. Here, TET2 is linked to acute myeloid leukemia.